These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 6381309

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Novel Multiplex Immunoassays for Quantification of IgG against Group B Streptococcus Capsular Polysaccharides in Human Sera.
    Buffi G, Galletti B, Stella M, Proietti D, Balducci E, Romano MR, Mori E, Fabbrini M, Giuliani MM, Berti F, Margarit I.
    mSphere; 2019 Aug 07; 4(4):. PubMed ID: 31391276
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Estimation of group B streptococcus type III polysaccharide-specific antibody concentrations in human sera is antigen dependent.
    Bhushan R, Anthony BF, Frasch CE.
    Infect Immun; 1998 Dec 07; 66(12):5848-53. PubMed ID: 9826364
    [Abstract] [Full Text] [Related]

  • 9. Natural acquired group B Streptococcus capsular polysaccharide and surface protein antibodies in HIV-infected and HIV-uninfected children.
    Dzanibe S, Adrian PV, Kimaro Mlacha SZ, Madhi SA.
    Vaccine; 2016 Oct 17; 34(44):5217-5224. PubMed ID: 27663669
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Class specificity of naturally acquired and vaccine-induced antibody to type III group B streptococcal capsular polysaccharide: determination with a radioimmunoprecipitin assay.
    Edwards MS, Fuselier PA, Rench MA, Kasper DL, Baker CJ.
    Infect Immun; 1984 May 17; 44(2):257-61. PubMed ID: 6370863
    [Abstract] [Full Text] [Related]

  • 15. L-ficolin and capsular polysaccharide-specific IgG in cord serum contribute synergistically to opsonophagocytic killing of serotype III and V group B streptococci.
    Fujieda M, Aoyagi Y, Matsubara K, Takeuchi Y, Fujimaki W, Matsushita M, Bohnsack JF, Takahashi S.
    Infect Immun; 2012 Jun 17; 80(6):2053-60. PubMed ID: 22451515
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Functional activity of class-specific antibodies to type III, group B streptococcus.
    Campbell JR, Baker CJ, Metzger TG, Edwards MS.
    Pediatr Res; 1988 Jan 17; 23(1):31-4. PubMed ID: 3277150
    [Abstract] [Full Text] [Related]

  • 19. Type-specific protection of neonatal rats from lethal group B streptococcal infection by immune sera obtained from human volunteers vaccinated with type III-specific polysaccharide.
    De Cueninck BJ, Eisenstein TK, McIntosh TS, Shockman GD, Swenson RM.
    Infect Immun; 1982 Sep 17; 37(3):961-5. PubMed ID: 6752032
    [Abstract] [Full Text] [Related]

  • 20. Safety and immunogenicity of capsular polysaccharide-tetanus toxoid conjugate vaccines for group B streptococcal types Ia and Ib.
    Baker CJ, Paoletti LC, Wessels MR, Guttormsen HK, Rench MA, Hickman ME, Kasper DL.
    J Infect Dis; 1999 Jan 17; 179(1):142-50. PubMed ID: 9841833
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.